THE IMPORTANCE OF BODY COMPOSITION MEASUREMENTS DURING LENVATINIB TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Yamaoka, Kenji [1 ]
Kawaoka, Tomokazu [1 ]
Kosaka, Masanari [1 ]
Johira, Yusuke [1 ]
Shirane, Yuki [1 ]
Miura, Ryoichi [1 ]
Yano, Shigeki [1 ]
Murakami, Serami [1 ]
Amioka, Kei [1 ]
Naruto, Kensuke [1 ]
Ando, Yuwa [1 ]
Kosaka, Yumi [1 ]
Uchikawa, Shinsuke [1 ]
Kodama, Kenichiro [1 ]
Uchida, Takuro [1 ]
Fujino, Hatsue [1 ]
Ono, Atsushi [1 ]
Nakahara, Takashi [1 ]
Murakami, Eisuke [1 ]
Okamoto, Wataru [2 ]
Yamauchi, Masami [1 ]
Miki, Daiki [1 ]
Imamura, Michio [1 ]
Chayama, Kazuaki [3 ]
Aikata, Hiroshi [1 ]
机构：
[1] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan
[2] Hiroshima Univ, Canc Treatment Ctr, Hiroshima, Japan
[3] Hiroshima Univ, Dept Collaborat Res Lab Med Innovat, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4508
引用
收藏
页码：S1386 / S1387
页数：2
相关论文
共 50 条
  • [41] Lenvatinib acts as the salvage therapy for advanced hepatocellular carcinoma
    Hsieh, M-C.
    Su, Y-L.
    Chen, Y-Y.
    Liu, C-T.
    Chen, Y-H.
    Chiu, T-J.
    Pei, S-N.
    Wu, C-C.
    Rau, K-M.
    ANNALS OF ONCOLOGY, 2018, 29 : 57 - 57
  • [42] Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular Carcinoma
    Yoshida, Ryoi
    Koroki, Keisuke
    Makishima, Hirokazu
    Ogasawara, Sadahisa
    Ishino, Takamasa
    Ogawa, Keita
    Nakagawa, Miyuki
    Fujiwara, Kisako
    Unozawa, Hidemi
    Iwanaga, Terunao
    Fujita, Naoto
    Sakuma, Takafumi
    Kanzaki, Hiroaki
    Kobayashi, Kazufumi
    Kanogawa, Naoya
    Kiyono, Soichiro
    Nakamura, Masato
    Kondo, Takayuki
    Saito, Tomoko
    Nakagawa, Ryo
    Suzuki, Eiichiro
    Ooka, Yoshihiko
    Nakamoto, Shingo
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Arai, Makoto
    Kaneko, Takashi
    Wakatsuki, Masaru
    Kato, Jun
    Tsuji, Hiroshi
    Kato, Naoya
    CASE REPORTS IN ONCOLOGY, 2021, 14 (02): : 1103 - 1110
  • [43] Colitis induced by Lenvatinib in a patient with advanced hepatocellular carcinoma
    Saori Miyajima
    Kunihiro Tsuji
    Yosuke Kito
    Naohiro Yoshida
    Kazuhiro Matsunaga
    Shigetsugu Tsuji
    Kazuyoshi Katayanagi
    Miwa Yonezawa
    Anna Kubo
    Kahori Ushijima
    Hiroshi Minato
    Hisashi Doyama
    Clinical Journal of Gastroenterology, 2021, 14 : 187 - 192
  • [44] Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis
    Quan Wang
    Xiaoquan Ji
    Jing Sun
    Wengang Li
    Xuezhang Duan
    Aimin Zhang
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7441 - 7452
  • [45] Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis
    Wang, Quan
    Ji, Xiaoquan
    Sun, Jing
    Li, Wengang
    Duan, Xuezhang
    Zhang, Aimin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7441 - 7452
  • [46] Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients
    Liu, Juanfang
    Li, Zhen
    Zhang, Wenguang
    Lu, Huibin
    Sun, Zhanguo
    Wang, Guozheng
    Han, Xinwei
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [47] Comparative analysis of liver functional reserve during lenvatinib and sorafenib for advanced hepatocellular carcinoma
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Toyama, Tadashi
    Shimakami, Tetsuro
    Takatori, Hajime
    Arai, Kuniaki
    Kawaguchi, Kazunori
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY RESEARCH, 2020, 50 (07) : 871 - 884
  • [48] Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment
    Chan, Kun-Ming
    Lai, Yin
    Hung, Hao-Chien
    Lee, Jin-Chiao
    Cheng, Chih-Hsien
    Wang, Yu-Chao
    Wu, Tsung-Han
    Lee, Chen-Fang
    Wu, Ting-Jung
    Chou, Hong-Shiue
    Wang, Ching-Ting
    Chai, Pei-Mei
    Lien, Hsin-Yi
    Lee, Wei-Chen
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 281 - 290
  • [49] Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma
    Uchida-Kobayashi, Sawako
    Kageyama, Ken
    Takemura, Shigekazu
    Matsumoto, Kazuhiro
    Odagiri, Naoshi
    Jogo, Atsushi
    Kotani, Kohei
    Kozuka, Ritsuzo
    Motoyama, Hiroyuki
    Kawamura, Etsushi
    Hagihara, Atsushi
    Yamamoto, Akira
    Fujii, Hideki
    Tanaka, Shogo
    Enomoto, Masaru
    Tamori, Akihiro
    Miki, Yukio
    Kubo, Shoji
    Kawada, Norifumi
    JGH OPEN, 2022, 6 (11): : 754 - 762
  • [50] Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma
    Yamaoka, Kenji
    Kodama, Kenichiro
    Hiramatsu, Akira
    Ando, Yuwa
    Kosaka, Yumi
    Suehiro, Yosuke
    Fujii, Yasutoshi
    Uchikawa, Shinsuke
    Morio, Kei
    Fujino, Hatsue
    Nakahara, Takashi
    Murakami, Eisuke
    Yamauchi, Masami
    Kawaoka, Tomokazu
    Miki, Daiki
    Tsuge, Masataka
    Imamura, Michio
    Takahashi, Shoichi
    Chayama, Kazuaki
    Aikata, Hiroshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (06) : 1685 - 1693
12345